These observations indicated that the X-NP-DOX drug-delivery system had improved antitumor effect at low dose by inhibiting invasion and metastasis, inducing apoptosis and targeting the cancer stem-like cells, decreasing the CD44+CD24low/– CSC population in vitro. Here, CD44 is linked to cancer.